Rosa Espin-Gomez
Murcia, MU, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Impact of Prior Biologic Mechanism of Action on Anti-TNF Effectiveness in Inflammatory Bowel Disease: An ENEIDA Registry Study.
Journal: Alimentary pharmacology & therapeutics
Published: March 14, 2026
Utility of tolerance assays for real-time management of infliximab infusion reactions.
Journal: Revista espanola de enfermedades digestivas
Published: January 22, 2026
STRATIfy-PK SCORE: A predictive tool for identifying pharmacokinetic failure risk in anti-TNF-treated patient.
Journal: British journal of clinical pharmacology
Published: July 16, 2025
Exploring infliximab serum level variability in inflammatory bowel disease: Comprehensive analysis of patient subgroups and treatment outcomes.
Journal: Gastroenterologia y hepatologia
Published: March 04, 2025
Impact of ustekinumab exposure on clinical outcomes during induction in inflammatory bowel disease.
Journal: Revista espanola de enfermedades digestivas
Published: December 04, 2024
Comparative effectiveness and drug survival of biosimilar infliximab CPT-13 vs. reference infliximab in inflammatory bowel disease: A retrospective cohort study.
Journal: Gastroenterologia y hepatologia
Published: May 18, 2023
Impact of proactive therapeutic drug monitoring of infliximab during the induction phase in IBD patients. A Bayesian approach.
Journal: Revista espanola de enfermedades digestivas
Published: December 23, 2022
Biosimilar infliximab CPT-13 for inflammatory bowel disease in a real clinical setting: pharmacokinetic outcomes, immunogenicity, and drug survival.
Journal: Revista espanola de enfermedades digestivas
Published: January 25, 2021
Association between ustekinumab trough concentrations and biochemical outcomes in patients with Crohn's disease. A real life study.
Journal: Revista espanola de enfermedades digestivas
Published: November 20, 2020
Spanish online survey on informed consent for the performance of paracentesis. Do we have it? Do we use it?
Journal: Revista espanola de enfermedades digestivas
Published: October 15, 2020
Usefulness of population pharmacokinetics to optimize the dosage regimen of infliximab in inflammatory bowel disease patients.
Journal: Revista espanola de enfermedades digestivas
Published: July 21, 2020
Usefulness of therapeutic drug monitoring of infliximab during the induction period in patients with inflammatory bowel disease.
Journal: Revista espanola de enfermedades digestivas
Published: April 28, 2020
Last Updated: 09/26/2026